173 related articles for article (PubMed ID: 37953981)
1. Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study.
Onwusah DO; Ojewole EB; Manyangadze T; Chimbari MJ
Patient Prefer Adherence; 2023; 17():2821-2839. PubMed ID: 37953981
[TBL] [Abstract][Full Text] [Related]
2. Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping Review.
Onwusah DO; Ojewole EB; Chimbari MJ
JCO Glob Oncol; 2023 Jan; 9():e2100289. PubMed ID: 36689700
[TBL] [Abstract][Full Text] [Related]
3. Predictors of adherence to oral anticancer medications: An analysis of 2010-2018 US nationwide claims.
Vyas A; Descoteaux A; Kogut S; Parikh MA; Campbell PJ; Green A; Westrich K
J Manag Care Spec Pharm; 2022 Aug; 28(8):831-844. PubMed ID: 35876294
[No Abstract] [Full Text] [Related]
4. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers.
Lin C; Clark R; Tu P; Bosworth HB; Zullig LL
Breast Cancer Res Treat; 2017 Sep; 165(2):247-260. PubMed ID: 28573448
[TBL] [Abstract][Full Text] [Related]
5. Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study.
Wells KJ; Pan TM; Vázquez-Otero C; Ung D; Ustjanauskas AE; Muñoz D; Laronga C; Roetzheim RG; Goldenstein M; Carrizosa C; Nuhaily S; Johnson K; Norton M; Sims E; Quinn GP
Support Care Cancer; 2016 Oct; 24(10):4123-30. PubMed ID: 27146492
[TBL] [Abstract][Full Text] [Related]
6. Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence.
Chong CC; Redzuan AM; Sathar J; Makmor-Bakry M
J Patient Exp; 2021; 8():2374373521996958. PubMed ID: 34179377
[TBL] [Abstract][Full Text] [Related]
7. Barriers and Facilitators of Using Sensored Medication Adherence Devices in a Diverse Sample of Patients With Multiple Myeloma: Qualitative Study.
Asfaw AA; Yan CH; Sweiss K; Wirth S; Ramirez VH; Patel PR; Sharp LK
JMIR Cancer; 2018 Nov; 4(2):e12. PubMed ID: 30425032
[TBL] [Abstract][Full Text] [Related]
8. Medication Adherence in Type 2 Diabetes Mellitus: A Qualitative Exploration of Barriers and Facilitators From Socioecological Perspectives.
Onwuchuluba EE; Oyetunde OO; Soremekun RO
J Patient Exp; 2021; 8():23743735211034338. PubMed ID: 34368436
[TBL] [Abstract][Full Text] [Related]
9. Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis.
Voshaar MJH; van den Bemt BJF; van de Laar MAFJ; van Dulmen AM; Vriezekolk JE
BMC Health Serv Res; 2022 Jan; 22(1):62. PubMed ID: 35022034
[TBL] [Abstract][Full Text] [Related]
10. Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study.
Conley CC; McIntyre M; Pensak NA; Lynce F; Graham D; Ismail-Khan R; Lopez K; Vadaparampil ST; O'Neill SC
Breast Cancer Res Treat; 2022 Apr; 192(2):385-399. PubMed ID: 34997364
[TBL] [Abstract][Full Text] [Related]
11. Using the theoretical domains framework to determine the barriers and facilitators to medication adherence in Parkinson's disease.
Smith JC; Seage CH; Lane E; James DH
Explor Res Clin Soc Pharm; 2023 Sep; 11():100309. PubMed ID: 37583935
[TBL] [Abstract][Full Text] [Related]
12. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
13. Women's Reports of Barriers to and Facilitators of Oral Medication Adherence During Ovarian Stimulation: A Mixed Methods Pilot Study.
Mahoney DE; Russell CL
J Reprod Infertil; 2021; 22(3):184-200. PubMed ID: 34900639
[TBL] [Abstract][Full Text] [Related]
14. Barriers and facilitators to adherence to secondary stroke prevention medications after stroke: analysis of survivors and caregivers views from an online stroke forum.
Jamison J; Sutton S; Mant J; De Simoni A
BMJ Open; 2017 Jul; 7(7):e016814. PubMed ID: 28713074
[TBL] [Abstract][Full Text] [Related]
15. Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.
Ho SC; Jacob SA; Tangiisuran B
PLoS One; 2017; 12(6):e0179290. PubMed ID: 28614368
[TBL] [Abstract][Full Text] [Related]
16. Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme.
Krummenacher I; Spencer B; Du Pasquier S; Bugnon O; Cavassini M; Schneider MP
Int J Clin Pharm; 2014 Aug; 36(4):716-24. PubMed ID: 24913358
[TBL] [Abstract][Full Text] [Related]
17. Patients' perspective of barriers and facilitators to taking long-term controller medication for asthma: a novel taxonomy.
Peláez S; Lamontagne AJ; Collin J; Gauthier A; Grad RM; Blais L; Lavoie KL; Bacon SL; Ernst P; Guay H; McKinney ML; Ducharme FM
BMC Pulm Med; 2015 Apr; 15():42. PubMed ID: 25907709
[TBL] [Abstract][Full Text] [Related]
18. A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments.
Schneider MP; Achtari Jeanneret L; Chevaux B; Backes C; Wagner AD; Bugnon O; Luthi F; Locatelli I
Front Pharmacol; 2018; 9():1567. PubMed ID: 30761009
[No Abstract] [Full Text] [Related]
19. Patients' perspective of disease and medication adherence for type 2 diabetes in an urban area in Bangladesh: a qualitative study.
Islam SM; Biswas T; Bhuiyan FA; Mustafa K; Islam A
BMC Res Notes; 2017 Mar; 10(1):131. PubMed ID: 28327202
[TBL] [Abstract][Full Text] [Related]
20. Factors Impacting Adherence to Diabetes Medication Among Urban, Low Income Mexican-Americans with Diabetes.
Baghikar S; Benitez A; Fernandez Piñeros P; Gao Y; Baig AA
J Immigr Minor Health; 2019 Dec; 21(6):1334-1341. PubMed ID: 30798408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
